Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cencora, Inc. Common Stock (NY:COR)

318.52 +4.38 (+1.39%)
Streaming Delayed Price Updated: 1:39 PM EDT, Apr 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
1 Large-Cap Stock for Long-Term Investors and 2 We Avoid
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Cencora (NYSE:COR)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
News headline image
Active ETFs Surge Past Passive, and These Are in the Lead ↗
Via MarketBeat
Topics ETFs
News headline image
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
From Cencora
Via Business Wire
Which S&P500 stocks have an unusual volume on Thursday? ↗
Via Chartmill
CENCORA INC (NYSE:COR) Passes the "Caviar Cruise" Quality Investing Screen ↗
Via Chartmill
Cencora Inc (NYSE:COR) Q1 2026 Earnings: Revenue Misses, EPS Beats, Shares Fall on Guidance ↗
Via Chartmill
News headline image
McKesson (MCK): A Deep-Dive into the Backbone of the Healthcare Supply Chain
In the complex, high-stakes machinery of the American healthcare system, few companies are as indispensable—yet as quietly influential—as McKesson Corporation (NYSE: MCK). As of March 18, 2026,... 
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Ignore
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
Which S&P500 stocks are moving on Tuesday? ↗
Via Chartmill
Tuesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
Tuesday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Cencora Announces Financial Leadership Transition
From Cencora
Via Business Wire
Thursday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
The Inventory Shield: US Wholesale Data Signals Stability as Markets Brace for New Trade Realities
The latest data from the U.S. Census Bureau, released in late February 2026, suggests a surprising degree of resilience within the American supply chain. Wholesale inventories for December 2025 rose by... 
Via MarketMinute
Topics Economy Supply Chain World Trade
News headline image
Investment Firm Bets Big on ESAB's Welding and Cutting Technology ↗
ESAB delivers welding, cutting, and digital solutions to industrial clients worldwide, spanning sectors from construction to energy. 
Via The Motley Fool
News headline image
Covetrus and MWI Animal Health to Merge
From Cencora
Via Business Wire
News headline image
Cencora Closes $3.0 Billion Senior Notes Offering
From Cencora
Via Business Wire
News headline image
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after a softer-than-expected inflation report fueled hopes for interest rate cuts by the Federal Reserve. The January Consumer Price Index (CPI), a... 
Via StockStory
Topics Economy
News headline image
1 Momentum Stock with Impressive Fundamentals and 2 We Question
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Cencora’s Q4 Earnings Call
Cencora's fourth quarter was marked by a negative market reaction, as revenue missed Wall Street’s expectations despite year-over-year growth. Management attributed performance to continued growth in... 
Via StockStory
Topics Earnings
News headline image
Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056
From Cencora
Via Business Wire
News headline image
McKesson (MCK): A Structural Re-rating Driven by Oncology and GLP-1 Momentum
McKesson Corporation (NYSE: MCK) stands today as the undisputed titan of the U.S. pharmaceutical supply chain. While the company has long been a staple of the Fortune 500, its relevance has surged in... 
Via Finterra
Topics Artificial Intelligence Economy Fraud
News headline image
Cencora (COR) Stock Trades Up, Here Is Why
Shares of healthcare distributor Cencora (NYSE:COR) jumped 7.1% in the afternoon session after the company reported first-quarter results that beat profit expectations and raised its full-year... 
Via StockStory
Topics Artificial Intelligence
Thursday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
Healthcare distributor Cencora (NYSE:COR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1%... 
Via StockStory
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Cencora (COR) Q1 2026 Earnings Call Transcript ↗
Cencora (COR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Cencora (NYSE:COR) Misses Q4 CY2025 Revenue Estimates
Healthcare distributor Cencora (NYSE:COR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.5% year on year to $85.93 billion. Its non-GAAP profit of $4.08 per share was 1% above... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS